Multi-Drug Resistant Organism (MDRO)
The Centers for Disease Control and Prevention today advised clinicians to report extensively drug-resistant strains of Shigella infections to their state or local health department, and educate patients and communities at increased risk.
The Centers for Disease Control and Prevention released recommendations for treating Extensively Drug-Resistant Salmonella Typhi, a systemic illness transmitted through contaminated food and water and person-to-person contact.
A report highlighting key findings from STRIVE (States Targeting Reduction in Infections via Engagement) - a national initiative funded by the Centers for Disease Control and Prevention (CDC) and aimed at improving infection control practices and strengthening health care-associated infection…
- Health Care Facility Management
- Performance improvement
- Planning, Design, and Construction
- Antibiotic Stewardship
- Infection Prevention and Control
- Hospital Acquired Condition (HAC)
- Catheter-Associated Urinary Tract Infection (CAUTI)
- Clostridium difficile (C. diff) Infection (CDI)
- Central Line-Associated Bloodstream Infection (CLABSI)
- Multi-Drug Resistant Organism (MDRO)
- AHA Center for Health Innovation